steven ratoff  eagle pharmaceuticals investor center toggle navigation menu investors login steven ratoff board member audit committee chair category board of directors emailpdfprintrss mr ratoff has served as a member of our board of directors since march  since december  mr ratoff has served as a venture partner of proquest investments since january  mr ratoff has served as president and chief executive officer of novadel pharma inc a private specialty pharmaceutical company and mr ratoff has served in a number of interim executive positions since joining novadel’s board of directors in may  mr ratoff has also served on novadel pharma inc’s board of directors since may  and currently serves as its chairman prior to novadel mr ratoff held various executive positions with cima labs inc a publiclytraded pharmaceutical company that was acquired by cephalon in  macromed inc a private drug development and manufacturing company that was acquired by protherics plc in  and brown forman corporation mr ratoff holds a bs in business administration from boston university and an mba from the university of michigan our board of directors believes that mr ratoff’s extensive executive experience and background in the global pharmaceutical and consumer products industries as well as his strong financial background qualifies him to serve on our board of directors nasdaq egrxstock info    minimum  minute delayrefresh data investor center home press releases corporate governanceboard of directors leadership team policies and charters board committee assignments stock information sec filings events  presentations analyst coverage investor faqs investor contacts search search this site advanced search registration login media requests email alerts rss feeds steven b ratoff  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in steven b ratoff board member at eagle pharmaceuticals inc view full profile are you steven b ratoff claim your profile   sign up for equilar atlas and view steven b ratoffs full profile with equilar atlas you can identify corporate executives in steven b ratoffs network and community follow changes in steven b ratoffs employment and moneyinmotion connect with steven b ratoff through your network of contacts steven b ratoffs executive work history current board member eagle pharmaceuticals inc past to view steven b ratoffs complete executive work history sign up now education bs boston university mba university of michigan age      steven b ratoffs biography steven b ratoff is a private investor who has served as a member of our board since march  mr ratoff has served since  as chairman of the board and chief executive officer of novadel pharma inc a formerly public specialty pharmaceutical company mr ratoffs prior experience includes serving as a venture partner for proquest investments from december  to december  and as chief executive officer of cima labs inc a specialty pharmaceutical company acquired by cephalon in  in addition mr ratoff served as chief financial officer of the brownforman company from  to  mr ratoff holds a bs in business admin  read more steven b ratoff is a private investor who has served as a member of our board since march  mr ratoff has served since  as chairman of the board and chief executive officer of novadel pharma inc a formerly public specialty pharmaceutical company mr ratoffs prior experience includes serving as a venture partner for proquest investments from december  to december  and as chief executive officer of cima labs inc a specialty pharmaceutical company acquired by cephalon in  in addition mr ratoff served as chief financial officer of the brownforman company from  to  mr ratoff holds a bs in business administration from boston university and an mba with distinction from the university of michigan our board believes that mr ratoffs extensive executive experience and background in the global pharmaceutical and consumer products industries as well as his strong financial background qualifies him to serve on our board source eagle pharmaceuticals inc on    sign up for equilar atlas and view steven b ratoffs full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like steven b ratoff more specifically youll be able to identify corporate executives in steven b ratoffs network and community follow changes in steven b ratoffs employment and moneyinmotion connect with steven b ratoff through your network of conections view full profile   search for over  executive profiles bio example steven b ratoff steven b ratoffs connections  sign up now to view steven b ratoffs  connections » phoebe a wood board member leggett  platt incorporated robert l glenning board member eagle pharmaceuticals inc david h bergstrom former senior vice president and chief operating officer novadel pharma inc david m pernock president and chief commercial officer eagle pharmaceuticals inc adrian j hepner executive vice president and chief medical officer eagle pharmaceuticals inc stephen e oneil board member alphatec holdings inc steven d cosler board member national retail properties inc jason s fisherman board member achillion pharmaceuticals inc jean w frydman former senior vice president legal general counsel and corporate secretary vitamin shoppe inc barry c cohen former vice president  business  new product development novadel pharma inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla jan koum board member facebook inc philip l milstein board member the marcus corporation × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   steven ratoff  proquest investments  zoominfocom steven ratoff novadel pharma inc profile  biography  bloomberg feedback steven ratoff chairman novadel pharma inc career history venture partner proquest investments present chairman novadel pharma inc present chairmanpresceointerim cfo novadel pharma inc  chairmanpresidentceo novadel pharma inc  chairmaninterim presidentceo novadel pharma inc  chairmaninterim presidentceo novadel pharma inc  chairman novadel pharma inc  chairman axonyx inc  chairmaninterim ceo cima labs inc  presidentceo macromed inc  exec vpcfo brownforman corp  various positions bristolmyers squibb co  show more website wwwnovadelcom corporate information address  route  east suite  bridgewater nj  united states phone  fax  web url wwwnovadelcom from the web personal information education university of michigan mba boston university bachelors degree business administration awards  publications certificates certified public accountant cpa memberships board memberships novadel pharma inc chairman present raptor therapeutics board member present eagle pharmaceuticals inc board member present novadel pharma inc chairman  novadel pharma inc chairman  axonyx inc chairman  novadel pharma inc board member  axonyx inc board member  inkine pharmaceuticals inc board member  inkine pharmaceutical co inc board member  cima labs inc chairman  cima labs inc board member  axonyx inc board member  macromed inc board member  show more sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data novadel pharma appoints steven b ratoff president and chief executive officer employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       novadel pharma nvd appoints steven b ratoff president and chief executive officer tweet   am flemington njbusiness wirenovadel pharma inc announced that the company’s board of directors has appointed steven b ratoff as president and chief executive officer effective january   mr ratoff has been chairman of the board since september  interim president and chief executive officer since july  and interim chief financial officer since april  mr ratoff will continue to serve as interim chief financial officer “with two products zolpimist™ and nitromist™ scheduled to enter the marketplace later this year and the acceleration of our promising product development program we have reached an exciting point in our company’s development and i am pleased to continue leading this effort” mr ratoff added “during the second half of  the company strengthened its balance sheet with proceeds received on closing two strategic licensing deals and the recently announced debt conversion” the company entered into an employment agreement with mr ratoff the material terms of which will be disclosed on a current report on form k to be filed by the company about novadel pharma novadel pharma inc is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs the company’s proprietary technology offers in comparison to conventional oral dosage forms the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly reduced first pass liver metabolism which may result in lower doses oral sprays eliminate the requirement for water or the need to swallow potentially improving patient convenience and adherence novadel’s oral spray technology is focused on addressing unmet medical needs for a broad array of existing and future pharmaceutical products the company’s most advanced oral spray candidates target cardiovascular and central nervous system disorders novadel plans to develop these and other products independently and through collaborative arrangements with pharmaceutical and biotechnology companies to find out more about novadel pharma inc otcbb nvdl  news visit our website at wwwnovadelcom forwardlooking statements except for historical information contained herein this document may contain forwardlooking statements within the meaning of the private securities litigation reform act of  these statements involve known and unknown risks and uncertainties that may cause the company’s actual results or outcomes to be materially different from those anticipated and discussed herein including but not limited to the ability of third parties to commercialize the company’s products the successful completion of its pilot pharmacokinetic feasibility studies the ability to develop products independently and through collaborative arrangements the company’s ability to obtain additional required financing to fund its research programs the ability to commercialize and obtain fda and other regulatory approvals for products under development and the acceptance in the marketplace for oral spray products the filing of an nda with the fda is an important step in the approval process in the united states acceptance for filing by the fda does not mean that the nda has been or will be approved nor does it represent an evaluation of the adequacy of the data submitted further the company operates in industries where securities may be volatile and may be influenced by regulatory and other factors beyond the company’s control in addition our inability to maintain or enter into and the risks resulting from our dependence upon collaboration or contractual arrangements necessary for the development manufacture commercialization marketing sales and distribution of any of our products could materially impact the companys actual results important factors that the company believes might cause such differences are discussed in the risk factors detailed in the company’s most recent annual report on form k and registration statements filed with the securities and exchange commission in assessing forwardlooking statements contained herein if any the reader is urged to carefully read all cautionary statements contained in such filings for more detailed information regarding novadel’s  financial results and its product pipeline please review the company’s sec filings on form q at the investor relations section of wwwnovadelcom contact novadel pharma inc steven b ratoff  ext  chairman president and chief executive officer sratoffnovadelcom read at biospacecom related news novadel pharma nvd announces agreement with debt holder to convert their notes to equity combinatorx incorporated crxx names new ceo novadel pharma nvd announces listing on otc bulletin board jdp therapeutics inc announces appointment of joshua m tarnoff to ceo novadel pharma nvd receives issue notification for new us patent covering its oral spray drug delivery technology clavis pharma asa appoints olav hellebo as chief executive officer novadel pharma nvd announces voluntary delisting from nyse amex llc and pending transfer to the overthecounter bulletin board thallion pharmaceuticals inc announces new ceo novadel pharma nvd signs exclusive license and distribution agreement with hitech pharmacal hitks subsidiary to commercialize and manufacture zolpimisttm in the us and canada stem cell company tcure gmbh appoints dr petra rueck and susanne knigge as coceos please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • novadel pharma inc   • biotechpharma  personnel                 novadel appoints steven b ratoff president and chief executive officer  business wire novadel appoints steven b ratoff president and chief executive officer january    am eastern standard time flemington njbusiness wirenovadel pharma inc the “company” otcbb nvdl announced that the company’s board of directors has appointed steven b ratoff as president and chief executive officer effective january   mr ratoff has been chairman of the board since september  interim president and chief executive officer since july  and interim chief financial officer since april  mr ratoff will continue to serve as interim chief financial officer “with two products zolpimist™ and nitromist™ scheduled to enter the marketplace later this year and the acceleration of our promising product development program we have reached an exciting point in our company’s development and i am pleased to continue leading this effort” mr ratoff added “during the second half of  the company strengthened its balance sheet with proceeds received on closing two strategic licensing deals and the recently announced debt conversion” the company entered into an employment agreement with mr ratoff the material terms of which will be disclosed on a current report on form k to be filed by the company about novadel pharma novadel pharma inc is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs the company’s proprietary technology offers in comparison to conventional oral dosage forms the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly reduced first pass liver metabolism which may result in lower doses oral sprays eliminate the requirement for water or the need to swallow potentially improving patient convenience and adherence novadel’s oral spray technology is focused on addressing unmet medical needs for a broad array of existing and future pharmaceutical products the company’s most advanced oral spray candidates target cardiovascular and central nervous system disorders novadel plans to develop these and other products independently and through collaborative arrangements with pharmaceutical and biotechnology companies to find out more about novadel pharma inc otcbb nvdl visit our website at wwwnovadelcom forwardlooking statements except for historical information contained herein this document may contain forwardlooking statements within the meaning of the private securities litigation reform act of  these statements involve known and unknown risks and uncertainties that may cause the company’s actual results or outcomes to be materially different from those anticipated and discussed herein including but not limited to the ability of third parties to commercialize the company’s products the successful completion of its pilot pharmacokinetic feasibility studies the ability to develop products independently and through collaborative arrangements the company’s ability to obtain additional required financing to fund its research programs the ability to commercialize and obtain fda and other regulatory approvals for products under development and the acceptance in the marketplace for oral spray products the filing of an nda with the fda is an important step in the approval process in the united states acceptance for filing by the fda does not mean that the nda has been or will be approved nor does it represent an evaluation of the adequacy of the data submitted further the company operates in industries where securities may be volatile and may be influenced by regulatory and other factors beyond the company’s control in addition our inability to maintain or enter into and the risks resulting from our dependence upon collaboration or contractual arrangements necessary for the development manufacture commercialization marketing sales and distribution of any of our products could materially impact the companys actual results important factors that the company believes might cause such differences are discussed in the risk factors detailed in the company’s most recent annual report on form k and registration statements filed with the securities and exchange commission in assessing forwardlooking statements contained herein if any the reader is urged to carefully read all cautionary statements contained in such filings for more detailed information regarding novadel’s  financial results and its product pipeline please review the company’s sec filings on form q at the investor relations section of wwwnovadelcom contacts novadel pharma incsteven b ratoff  ext chairman president and chief executive officersratoffnovadelcom release summary novadel pharma inc announced that the company’s board of directors has appointed steven b ratoff as president and chief executive officer effective january   contacts novadel pharma incsteven b ratoff  ext chairman president and chief executive officersratoffnovadelcom search advanced news search advanced news search log in sign up egrx steven b ratoff insider trades for eagle pharmaceuticals inc bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close eagle pharmaceuticals inc nasdaq egrx go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus eagle pharmaceuticals inc after hours  quotes are delayed by  min jul    pm egrx quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual steven b ratoff mr steven b ratoff is independent nonemployee director at eagle pharmaceuticals inc and chairman president  chief executive officer at novadel pharma inc he is on the board of directors at eagle pharmaceuticals inc mr ratoff was previously employed as chairman by torreypines therapeutics inc venture partner by proquest management llc president  chief executive officer by macromed inc chairman  interim chief executive officer by cima labs inc chief financial officer  executive vice president by brownforman corp chief financial officer  senior vice president by bristolmyers squibb co and a principal by arthur andersen llp he also served on the board at inkine pharmaceutical co inc and axonyx inc he received his undergraduate degree from boston university and an mba from the university of michigan transactions date shares transaction value     disposition at  per share      disposition at  per share      acquisition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr michael graves chairman mr david m pernock president  chief commercial officer mr scott l tarriff chief executive officer  director mr peter a meyers chief financial  accounting officer dr adrian hepner evpclinical research  regulatory affairs dr peter e grebow executive vice presidentresearch  development dr steven l krill chief scientific officer  evp mr john larocca chief compliance officer evp  general counsel mr richard a edling director ms sherry korczynski senior vice presidentmarketing mr ken degen senior vice presidentsales  marketing dr paul bruinenberg chief medical officer  headresearch mr robert l glenning director mr douglas lee braunstein director mr sander a flaum independent nonemployee director mr steven b ratoff independent nonemployee director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money pus giving takeover bids by chinese firms much tougher look pjared kushner discloses dozens of additional assets in revised filing pbitcoin surges as miners avert split for now palphabet earnings a  billion hit for google potential youtube results for investors ahow opec committee’s coming meeting could make or break oil prices aa grandfather’s financial advice to his grandchildren awhy one analyst calls this the ‘chart of the week month and potentially year’ athe cracked benchmark why some investors want a new standard for bonds a moneymaking lessons from the richest man who ever lived loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  proquest investments  investment team steven ratoff venture partner mr ratoff joined proquest as a venture partner in  mr ratoff is a seasoned executive with extensive experience in the global pharmaceutical and consumer products industries prior to joining proquest mr ratoff served as chairman and interim ceo of cima labs inc he also served as president and ceo of macromed inc previously mr ratoff served as executive vice president and chief financial officer of brownforman corporation a public diversified manufacturer of consumer products he has also held a number of senior financial positions at bristolmyers squibb including senior vice president and chief financial officer of the pharmaceutical group prior to joining bristolmyers mr ratoff worked at arthur andersen  co mr ratoff received a bs in business administration from boston university and an mba with distinction from the university of michigan cima labs  letter agreement  steven b ratoff looking for an agreement search from over  million agreements now sign in  shopping cart home  agreement preview letter agreement  steven b ratoff this is an actual contract by cima labs browse the agreement preview below and buy the entire agreement for  sectors biotechnology  pharmaceuticals governing law minnesota view minnesota state laws effective date may   save time and money with our premium packages  savings search this document searching please wait exhibit  cima labs inc employment agreement this employment agreement this agreement is entered into on april   by and between cima labs inc a delaware corporation with its headquarters in eden prairie minnesota the company and steven b ratoff a resident of arizona executive a the company develops and manufactures prescription and overthecounter pharmaceutical products using fastdissolve drug delivery technologies for sale around the world b executive is an experienced business manager in the pharmaceutical industry and is chairman of the board of directors of the company c the companys president and chief executive officer has announced his retirement from the company effective december   and from his position as president and chief executive officer effective april   d the company desires for executive to serve as interim chief executive officer while it completes a search for candidates for the position and executive desires to serve in this capacity subject to the terms and conditions set forth in this agreement now therefore in consideration of the foregoing premises and the respective agreements of the company and executive set forth below the company and executive intending to be legally bound agree as follows  employment effective as of may   the company shall employ executive and executive shall accept such employment and perform services for the company upon the terms and conditions set forth in this agreement  term of employment unless terminated at an earlier date in accordance with section  hereof the term of executives employment with the company shall be for the period commencing on may   and ending on october   the term  position and duties a employment with the company during executives employment with the company hereunder executive shall report to the board of directors of the company the board and shall perform such duties and responsibilities as the board shall assign to him from time to time consistent with his position executive shall be an executive officer of the company and executives title shall be interim chief executive officer b board of directors executive is currently a member and chairman of the board while executive is employed hereunder executive shall not receive any additional compensation from the company in connection with his service as a director or chairman c performance of duties and responsibilities executive shall serve the company faithfully and to the best of his ability and shall devote his full working time attention and efforts to the business of the company during his employment with the company executive hereby represents and confirms that he is under no contractual or legal commitments that would prevent him from fulfilling his duties and responsibilities as set forth in this agreement during his employment with the company executive may participate in charitable activities and personal investment activities to a reasonable extent and subject to prior board approval may serve on boards of directors of other companies so long as such activities do not interfere with the performance of his duties and responsibilities hereunder the company acknowledges and consents to executives service on the board of directors of inkine pharmaceutical company inc d location while executive is employed by the company hereunder his employment shall be based at the companys headquarters in eden prairie minnesota executive shall be available at the headquarters of the company as reasonably required to carry out his duties and responsibilities hereunder  compensation a base salary while executive is employed by the company hereunder the company shall pay to executive a monthly base salary of  less deductions and withholdings which base salary shall be paid in accordance with the companys normal payroll policies and procedures b incentive bonus while executive is employed by the company hereunder executive shall be eligible for an incentive bonus award of up to  of executives base salary based upon achievement of defined objectives to be determined in the sole discretion of the board c stock options subject to approval by the board and the terms of a definitive stock option agreement to be entered into by the company and executive the company shall grant executive a stock option to purchase  shares of common stock of the company which option shall vest  upon commencement of executives employment hereunder and  on the first anniversary of the commencement of executives employment hereunder provided that executive continues as an employee consultant or director of the company on such anniversary date d employee benefits except as specifically stated in this agreement while executive is employed by the company hereunder executive shall not be entitled to participate in any employee benefit plans or programs of the company executive hereby waives all right and interest he may have to benefits under such plans including without limitation all medical  and dental plans life and disability insurance plans and retirement or pension plans sponsored by the company e expenses while executive is employed by the company hereunder the company shall reimburse executive for all reasonable and necessary outofpocket business travel and entertainment expenses incurred by him in the performance of his duties and responsibilities hereunder subject to the companys normal policies and procedures for expense verification and documentation the company shall also provide appropriate living and travel arrangements for executive in the minneapolis minnesota metropolitan area if any of the payments made by the company as described in this section e are determined to be income to executive for federal income tax purposes the company shall also pay to executive an additional amount equal to  of the amount determined to be income f vacation while executive is employed by the company hereunder executive shall receive two  weeks paid vacation time off vacation time shall be taken at such times so as not to unduly disrupt the operations of the company  confidential information except as permitted by the companys board during the term of executives employment with the company and at all times thereafter executive shall not divulge furnish or make accessible to anyone or use in any way other than in the ordinary course of the business of the company any confidential proprietary or secret knowledge or information of the company that executive has acquired or shall acquire during his employment with the company whether developed by himself or by others concerning i any trade secrets ii any confidential proprietary or secret designs processes formulae plans devices or material whether or not patented or patentable directly or indirectly useful in any aspect of the business of the company iii any customer or supplier lists of the company iv any confidential proprietary or secret development or research work of the company v any strategic or other business marketing or sales plans of the company vi any financial data or plans respecting the company or vii any other confidential or proprietary information or secret aspects of the business of the company executive acknowledges that the abovedescribed knowledge and information constitutes a unique and valuable asset of the company and represents a substantial investment of time and expense by the company and that any disclosure or other use of such knowledge or information other than for the sole benefit of the company would be wrongful and would cause irreparable harm to the company during the term of executives employment with the company executive shall refrain from any acts or omissions that would reduce the value of such knowledge or information to the company the foregoing obligations of confidentiality shall not apply to any knowledge or information that i is now or subsequently becomes generally publicly known in the form in which it was obtained from the company ii is independently made available to executive in good faith by a third party who has not violated a confidential relationship with the company or iii is required to be disclosed by legal process other than as a direct or indirect result of the breach of this agreement by executive  ventures if during the term of executives employment with the company executive is engaged in or associated with the planning or implementing of any  project program or venture involving the company and a third party or parties all rights in such project program or venture shall belong to the company except as approved in writing by the board executive shall not be entitled to any interest in any such project program or venture or to any commission finders fee or other compensation in connection therewith other than the compensation to be paid to executive by the company as provided herein executive shall have no interest direct or indirect in any customer or supplier that conducts business with the company unless such interest has been disclosed in writing to and approved by the board before such customer or supplier seeks to do business with the company ownership by executive as a passive investment of less than  of the outstanding shares of capital stock of any corporation listed on a national securities exchange or publicly traded in the overthecounter market shall not constitute a breach of this section   noncompetition covenant a agreement not to compete during the term of executives employment with the company and for a period of twelve  consecutive months from the date of the termination of such employment whether such termination is with or without cause as defin  end of preview  view other agreements from cima labs agreements cima labs  chief financial officer employment agreement cima labs  chief executive officer employment agreement cima labs  amendment to supply agreement cima labs  amendment to development license agreement cima labs   directors stock option plan home about us faq subscription  contact us  privacy policy   terms of service    copyright socratek llc  steven b ratoff chmn novadel pharma inc a publisher of business information since         search business search executive   advanced search   sign in    hints profile of steven ratoff   steven ratoff   chmn  novadel pharma inc   steven ratoff email  please login   company name  novadel pharma inc   company website  wwwnovadelcom   company address   minneakoning rd flemington njunited states   steven ratoff profile  chmn  novadel pharma inc   steven ratoff biography  mr ratoff was appointed by novadels board in july  to serve as interim president and ceomr ratoff a private investor joined our board in january  and was elected chairman of the board in september  mr ratoff has served as a venture partner with proquest investments a health care venture capital firm and is a member of the board of directors of torreypines therapeutics inc he also served as chairman of the board and interim ceo of cima labs inc prior to its sale to cephalon inc and as senior vp and cfo of the pharmaceutical group at bristolmyers squibb mr ratoff brings extensive credentials to the company from his distinguished career in the pharmaceutical and consumer goods industriesmr ratoff received his bs in business administration from boston university and an mba with distinction from the university of michigan mr ratoff is also a retired certified public accountant   steven ratoff colleagues  name title email william hamilton board dir please login thomas bonney board dir please login jan egberts dir ceo pres please login jay lobell board dir please login charles nemeroff board dir please login             home    about us    product information     subscription    list builder     executive list     email lists     contact us    site map    browse directory      �  walkerss research  a publisher of business information since  all rights reserved